Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEXT: Axitinib in Recurrent Renal Cell Carcinoma
NCT01649180Phase 2Terminated
- Sponsor
- PrECOG
- Start
- Jul 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in renal cell carcinoma (RCC), sponsored by PrECOG. Started Jul 2012; status: terminated.
02
Drugs
axitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01649180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649180.